Skip to main content
Premium Trial:

Request an Annual Quote

Frank Gentile, Steve Lombardi, Norrie Russell, Peter Wilding, Charles Sie, Alan Guttmacher, Vence Bonham, Jr.


Frank Gentile has left his position as vice president for technology program management at Millennium Pharmaceuticals to join Boston-based investment firm Hambrecht & Quist Capital Management as vice president of research. Prior to working at Millennium, Gentile was vice president for product development at Curis. He is also an adjunct associate professor of biotechnology at Brown University. Gentile holds a BSE from the Cooper Union for the Advancement of Science and Art and a PhD in chemical engineering from MIT.

Affymetrix said last week it had hired Applied Biosystems’ Steve Lombardi as vice president of corporate development where he will be involved in early stage product development. Lombardi was previously senior vice president of applications and products for ABI, where he managed product marketing, brand marketing, and strategic planning. In 16 years at the company, he also held positions as vice president of field operations in the Americas and vice president of genetic analysis.

Aviva Biosciences last week hired Norrie Russell as CEO, three months after he resigned as CEO of Lynx Therapeutics. Russell replaces Peter Wilding, who will become chairman of the biochip developers’ board of directors. Charles Sie, who has served as chairman of the board since Aviva’s founding, will continue to hold a seat on the board of directors.

Alan Guttmacher was named deputy director of the National Human Genome Research Institute on Sept. 9. Guttmacher will help guide the institute’s research following the windup of the Human Genome Project, including applying genomic science to new diagnostics and therapies for disease.

Guttmacher, a medical geneticist with the University of Vermont College of Medicine, joined NHGRI in 1999 as senior clinical advisor to the director. In April, he also took on the role of acting director of the NHGRI office of planning, policy, and communications.

His role at the agency involved acting as a liaison between clinicians, the genome-research community, and the public, and promoting larger public and medical understanding of the Human Genome Project.

Guttmacher replaces Elke Jordan, who announced her retirement last spring.

The institute also announced that it had brought on Vence Bonham, Jr., as senior consultant to the director on health disparities. Bonham, a health-policy researcher and associate professor at Michigan State University, will assist the director in outreach and programs for reducing disparities in health.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.